Literature DB >> 9536549

Topical glyceryl trinitrate: a possible treatment for cutaneous leishmaniasis.

B Zeina1, C Banfield, S al-Assad.   

Abstract

The treatment of cutaneous leishmaniasis (CL) is difficult in both the old and new worlds. However, nitric oxide (NO) is involved in host cell mediated immune responses against intracellular parasites such as Leishmania major, and both in vitro and in vivo immunological studies indicate that Leishmania parasite killing by macrophages is mediated by this substance. Glyceryl trinitrate (GTN) is an exogenous NO donor; we have successfully treated a young man with cutaneous leishmaniasis with topical GTN. We believe this to be the first reported use of GTN in the treatment of human CL.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9536549

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  4 in total

1.  In Vitro Study of Nitric Oxide Metabolites Effects on Human Hydatid of Echinococcus granulosus.

Authors:  Razika Zeghir-Bouteldja; Manel Amri; Saliha Aitaissa; Samia Bouaziz; Dalila Mezioug; Chafia Touil-Boukoffa
Journal:  J Parasitol Res       Date:  2009-12-13

2.  Anti-leishmanial effects of trinitroglycerin in BALB/C mice infected with Leishmania major via nitric oxide pathway.

Authors:  Hossein Nahrevanian; Mana Najafzadeh; Reza Hajihosseini; Habib Nazem; Mahin Farahmand; Zahra Zamani
Journal:  Korean J Parasitol       Date:  2009-05-27       Impact factor: 1.341

3.  Nitric oxide-mediated proteasome-dependent oligonucleosomal DNA fragmentation in Leishmania amazonensis amastigotes.

Authors:  Philippe Holzmuller; Denis Sereno; Mireille Cavaleyra; Isabelle Mangot; Sylvie Daulouede; Philippe Vincendeau; Jean-Loup Lemesre
Journal:  Infect Immun       Date:  2002-07       Impact factor: 3.441

Review 4.  Use of nitric oxide nanoparticulate platform for the treatment of skin and soft tissue infections.

Authors:  Allison J Kutner; Adam J Friedman
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2013-05-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.